- Home
- CHRS vs FNKO Comparison
CHRS vs FNKO Comparison
Compare CHRS & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- FNKO
- Stock Information
- Founded
- CHRS 2010
- FNKO 2017
- Country
- CHRS United States
- FNKO United States
- Employees
- CHRS N/A
- FNKO N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- FNKO Recreational Games/Products/Toys
- Sector
- CHRS Health Care
- FNKO Consumer Discretionary
- Exchange
- CHRS Nasdaq
- FNKO Nasdaq
- Market Cap
- CHRS 186.0M
- FNKO 164.8M
- IPO Year
- CHRS 2014
- FNKO 2017
- Fundamental
- Price
- CHRS $1.11
- FNKO $2.86
- Analyst Decision
- CHRS Strong Buy
- FNKO Buy
- Analyst Count
- CHRS 4
- FNKO 4
- Target Price
- CHRS $4.51
- FNKO $7.13
- AVG Volume (30 Days)
- CHRS 1.4M
- FNKO 1.1M
- Earning Date
- CHRS 11-06-2025
- FNKO 11-06-2025
- Dividend Yield
- CHRS N/A
- FNKO N/A
- EPS Growth
- CHRS N/A
- FNKO N/A
- EPS
- CHRS 1.34
- FNKO N/A
- Revenue
- CHRS $277,728,000.00
- FNKO $928,842,000.00
- Revenue This Year
- CHRS N/A
- FNKO N/A
- Revenue Next Year
- CHRS $109.48
- FNKO $10.57
- P/E Ratio
- CHRS $0.82
- FNKO N/A
- Revenue Growth
- CHRS 152.07
- FNKO N/A
- 52 Week Low
- CHRS $0.71
- FNKO $2.22
- 52 Week High
- CHRS $2.43
- FNKO $14.65
- Technical
- Relative Strength Index (RSI)
- CHRS 31.08
- FNKO 40.65
- Support Level
- CHRS $1.09
- FNKO $2.93
- Resistance Level
- CHRS $1.25
- FNKO $3.97
- Average True Range (ATR)
- CHRS 0.13
- FNKO 0.27
- MACD
- CHRS -0.04
- FNKO -0.04
- Stochastic Oscillator
- CHRS 0.81
- FNKO 0.81
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.